HYDREA Safety Questions, HYDREA Answers
More Here>>Side Effects - FDA Reports 2006-2008
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y ZWelcome! Patientsville.com provides unique information about HYDREA. Our extensive database of HYDREA adverse events and HYDREA warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.
>> Announcements
Check out our Hospital and Home Care Quality Reports.
Ask Our Health Experts about HYDREA
HYDREA Safety Reports
Total HYDREA reports: 48.HYDREA FDA safety alerts: 2006 .
Reported deaths: 13 Reported hospitalizations: 25.
Take HYDREA Side Effects Survey or Share Your HYDREA Story. Read More Here.
Consumer or non-health professional from JAPAN reported HYDREA problem on Dec 25, 2006. Male patient, 77 years of age, was diagnosed with essential thrombocythaemia and was treated with HYDREA. After drug was administered, patient experienced the following problems/side effects: nocardiosis. HYDREA dosage: unknown. Patient died.
HYDREA problem was reported by a Health Professional from FRANCE on Jan 10, 2007. Female patient, 55 years of age, weighting 180.8 lb, was diagnosed with myelopathy and was treated with HYDREA. After drug was administered, patient experienced the following problems/side effects: ascites, asthenia, cardiac failure, cardiogenic shock, dyspnoea. HYDREA dosage: unknown. During the same period patient was treated with ASPEGIC. Patient was hospitalized. Patient died on 12/04/2006.
Physician from JAPAN reported HYDREA problem on Jan 10, 2007. Female patient, 77 years of age, was diagnosed with essential thrombocythaemia and was treated with HYDREA. After drug was administered, patient experienced the following problems/side effects: small intestine ulcer. HYDREA dosage: unknown. During the same period patient was treated with ASPIRIN, GASMOTIN, TAKEPRON. Patient was hospitalized. Patient recovered.
HYDREA problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Jan 22, 2007. Male patient, 62 years of age, was diagnosed with essential thrombocythaemia and was treated with HYDREA. After drug was administered, patient experienced the following problems/side effects: malignant melanoma. HYDREA dosage: unknown. Patient recovered.
Health Professional from FRANCE reported HYDREA problem on Jan 24, 2007. Male patient, 73 years of age, weighting 114.6 lb, was diagnosed with chronic myeloid leukaemia and was treated with HYDREA. HYDREA dosage: unknown. During the same period patient was treated with DAFALGAN CAPS, RIVOTRIL, PLAVIX, TARDYFERON, SPECIAFOLDINE, NEURONTIN, FONZYLANE, ACTISKENAN CAPS. Patient was hospitalized. Patient died on 10/25/2006.
HYDREA problem was reported by a Health Professional from FRANCE on Feb 14, 2007. Male patient, 33 years of age, was treated with HYDREA. After drug was administered, patient experienced the following problems/side effects: alopecia, erythema, muscle fatigue, nail dystrophy, skin ulcer, squamous cell carcinoma, stomatitis. HYDREA dosage: unknown. During the same period patient was treated with ALLOPURINOL. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from BRAZIL reported HYDREA problem on Mar 07, 2007. Female patient, 60 years of age, weighting 132.3 lb, was diagnosed with platelet count increased, hypothyroidism, diabetes mellitus and was treated with HYDREA. After drug was administered, patient experienced the following problems/side effects: anaphylactic shock, dizziness, malaise, nausea. HYDREA dosage: unknown. During the same period patient was treated with PURAN T, METFORMIN, PENTOXIFYLLINE. Patient was hospitalized. Patient recovered.
HYDREA problem was reported by a Consumer or non-health professional from BRAZIL on Mar 12, 2007. Female patient, 60 years of age, weighting 132.3 lb, was diagnosed with platelet count increased, hypothyroidism, diabetes mellitus and was treated with HYDREA. After drug was administered, patient experienced the following problems/side effects: anaphylactic shock, dizziness, malaise, nausea, pruritus, urticaria. HYDREA dosage: unknown. During the same period patient was treated with PURAN T, METFORMIN, PENTOXIFYLLINE. Patient was hospitalized. Patient recovered.
Health Professional from FRANCE reported HYDREA problem on Mar 16, 2007. Female patient, 55 years of age, weighting 180.8 lb, was diagnosed with myelopathy and was treated with HYDREA. After drug was administered, patient experienced the following problems/side effects: ascites, asthenia, cardiac failure, cardiogenic shock, dyspnoea. HYDREA dosage: unknown. During the same period patient was treated with ASPEGIC. Patient was hospitalized. Patient died on 12/04/2006.
HYDREA problem was reported by a Health Professional from FRANCE on Mar 16, 2007. Female patient, 55 years of age, was diagnosed with myelofibrosis and was treated with HYDREA. After drug was administered, patient experienced the following problems/side effects: cardiac failure. HYDREA dosage: unknown. Patient was hospitalized. Patient recovered.
Physician from FRANCE reported HYDREA problem on Mar 22, 2007. Female patient, 35 years of age, was diagnosed with thrombocythaemia and was treated with HYDREA. After drug was administered, patient experienced the following problems/side effects: abortion, pregnancy. HYDREA dosage: unknown. Patient recovered.
HYDREA problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 13, 2006. Female patient, 79 years of age, weighting 125.7 lb, was diagnosed with laboratory test abnormal and was treated with HYDREA. After drug was administered, patient experienced the following problems/side effects: restless legs syndrome. HYDREA dosage: unknown. Patient recovered.
Consumer or non-health professional from UNITED STATES reported HYDREA problem on Apr 04, 2006. Female patient, 80 years of age, weighting 154.3 lb, was diagnosed with thrombocytopenia and was treated with HYDREA. After drug was administered, patient experienced the following problems/side effects: pruritus, rash. HYDREA dosage: unknown. During the same period patient was treated with THYROID SUPPLEMENT. Patient recovered.
HYDREA problem was reported by a Consumer or non-health professional from UNITED STATES on May 09, 2006. Male patient, 74 years of age, weighting 196.2 lb, was diagnosed with polycythaemia and was treated with HYDREA. After drug was administered, patient experienced the following problems/side effects: fatigue, increased tendency to bruise, rash. HYDREA dosage: unknown. During the same period patient was treated with PROSCAR. Patient recovered.
Consumer or non-health professional from UNITED STATES reported HYDREA problem on June 08, 2006. Female patient, 87 years of age, weighting 152.1 lb, was diagnosed with essential thrombocythaemia and was treated with HYDREA. After drug was administered, patient experienced the following problems/side effects: platelet count increased, red blood cell count increased, white blood cell count decreased. HYDREA dosage: unknown. During the same period patient was treated with SYNTHROID, COZAAR, CALCIUM. Patient recovered.
HYDREA problem was reported by a Consumer or non-health professional from UNITED STATES on July 21, 2006. Female patient, 77 years of age, weighting 119.0 lb, was diagnosed with red blood cell count increased and was treated with HYDREA. After drug was administered, patient experienced the following problems/side effects: dysgeusia, headache. HYDREA dosage: unknown. During the same period patient was treated with ASPIRIN, FOSAMAX, ASCORBIC ACID. Patient recovered.
Consumer or non-health professional from UNITED STATES reported HYDREA problem on Aug 02, 2006. Female patient, weighting 110.2 lb, was diagnosed with polycythaemia vera and was treated with HYDREA. After drug was administered, patient experienced the following problems/side effects: pain in extremity. HYDREA dosage: unknown. During the same period patient was treated with TYLENOL, ASPIRIN. Patient recovered.
HYDREA problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 22, 2006. Female patient, weighting 143.3 lb, was diagnosed with myelofibrosis and was treated with HYDREA. After drug was administered, patient experienced the following problems/side effects: gastritis, nausea. HYDREA dosage: 2 500 MG TABLETS DAILY X 1 DAY, THEN 1 500 MG TABLET X 2 DAYS, THEN REPEAT. During the same period patient was treated with GAVISCON, MYLANTA, LOTREL, PREVACID, ZOCOR. Patient recovered.
Physician from UNITED STATES reported HYDREA problem on Oct 04, 2006. Male patient, 29 years of age, weighting 291.0 lb, was diagnosed with thrombocytopenia, gastritis and was treated with HYDREA. After drug was administered, patient experienced the following problems/side effects: gastritis. HYDREA dosage: unknown. During the same period patient was treated with ASPIRIN, PEPCID, PREVACID. Patient recovered.
HYDREA problem was reported by a Health Professional from FRANCE on June 18, 2007. Female patient, 75 years of age, was diagnosed with thrombocytopenia, breast cancer and was treated with HYDREA. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia. HYDREA dosage: unknown. During the same period patient was treated with TAXOL, HERCEPTIN, CARBOPLATIN, ARIMIDEX. Patient was hospitalized. Patient died on 09/01/2006.
Health Professional from SWEDEN reported HYDREA problem on June 20, 2007. Female patient, 83 years of age, was diagnosed with thrombocytopenia and was treated with HYDREA. After drug was administered, patient experienced the following problems/side effects: bone marrow failure, epistaxis, haematochezia, haematuria, haemoglobin decreased. HYDREA dosage: unknown. During the same period patient was treated with WARAN, OMEPRAZOLE, FURIX, IMODIUM, LINATIL. Patient was hospitalized. Patient recovered.
HYDREA problem was reported by a Consumer or non-health professional from SWEDEN on June 15, 2007. Male patient, 81 years of age, was diagnosed with chronic myeloid leukaemia and was treated with HYDREA. After drug was administered, patient experienced the following problems/side effects: amyloidosis, arteriosclerosis, bence jones proteinuria, blood creatinine increased, blood uric acid increased, dialysis, haemoglobin decreased, nephropathy, renal failure. HYDREA dosage: unknown. During the same period patient was treated with FURIX, KALCIDON, GLEEVEC. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from BRAZIL reported HYDREA problem on June 27, 2007. Male patient, 50 years of age, weighting 172.0 lb, was diagnosed with chronic leukaemia and was treated with HYDREA. After drug was administered, patient experienced the following problems/side effects: accidental overdose, anorexia, asphyxia, aspiration bone marrow abnormal, asthenia, blood disorder, burning sensation, cardiovascular disorder, haematemesis. HYDREA dosage: unknown. Patient was hospitalized. Patient recovered.
HYDREA problem was reported by a Physician from UNITED STATES on Mar 08, 2006. Female patient, 78 years of age, was diagnosed with essential thrombocythaemia and was treated with HYDREA. After drug was administered, patient experienced the following problems/side effects: disease progression, lung disorder. HYDREA dosage: unknown. During the same period patient was treated with NITROSTAT, LIBRIUM, TIAZAC, COUMADIN, SYNTHROID, CODEINE, CLONIDINE, LISINOPRIL. Patient died on 09/29/2005.
Physician from FRANCE reported HYDREA problem on Apr 04, 2006. Male patient, 56 years of age, was diagnosed with red blood cell count increased and was treated with HYDREA. After drug was administered, patient experienced the following problems/side effects: eczema, toxic skin eruption, viral infection. HYDREA dosage: unknown. During the same period patient was treated with FRACTAL, ASPIRIN. Patient was hospitalized. Patient recovered.
HYDREA problem was reported by a Pharmacist from UNITED STATES on July 21, 2006. Female patient, 51 years of age, weighting 99.21 lb, was treated with HYDREA. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, cardio-respiratory arrest, eosinophilia, nephritis interstitial, thrombocytopenia. HYDREA dosage: 500MG DAILY PO. During the same period patient was treated with VANCOMYCIN. Patient died on 06/26/2006.
Health Professional from FRANCE reported HYDREA problem on July 18, 2006. Female patient, 74 years of age, weighting 127.9 lb, was diagnosed with chronic myeloid leukaemia and was treated with HYDREA. After drug was administered, patient experienced the following problems/side effects: lung neoplasm malignant, treatment related secondary malignancy. HYDREA dosage: unknown. Patient was hospitalized. Patient recovered.
HYDREA problem was reported by a Health Professional from JAPAN on Apr 19, 2006. Male patient, 69 years of age, was diagnosed with polycythaemia vera and was treated with HYDREA. After drug was administered, patient experienced the following problems/side effects: skin ulcer, tumour necrosis. HYDREA dosage: unknown. During the same period patient was treated with DIART, NORVASC, WARFARIN. Patient was hospitalized. Patient recovered.
Physician from FRANCE reported HYDREA problem on June 12, 2006. Male patient, 54 years of age, was diagnosed with thrombocytopenia, hypertension, tooth extraction, sinobronchitis and was treated with HYDREA. After drug was administered, patient experienced the following problems/side effects: cytolytic hepatitis, gingival bleeding, hepatitis cholestatic, hepatocellular damage, hepatomegaly. HYDREA dosage: unknown. During the same period patient was treated with TENORMIN, AMLODIPINE BESYLATE, RODOGYL, OFLOCET. Patient recovered.
HYDREA problem was reported by a Health Professional from FRANCE on July 18, 2006. Female patient, 74 years of age, weighting 127.9 lb, was diagnosed with chronic myeloid leukaemia and was treated with HYDREA. After drug was administered, patient experienced the following problems/side effects: lung neoplasm malignant, treatment related secondary malignancy. HYDREA dosage: unknown. Patient was hospitalized. Patient recovered.
Physician from JAPAN reported HYDREA problem on Dec 01, 2005. Female patient, 67 years of age, was diagnosed with essential thrombocythaemia and was treated with HYDREA. After drug was administered, patient experienced the following problems/side effects: hodgkin's disease, treatment related secondary malignancy. HYDREA dosage: unknown. During the same period patient was treated with ADRIAMYCIN PFS, BLEOMYCIN, VINCREX SULPHATE, DACARBAZINE. Patient was hospitalized. Patient died.
HYDREA problem was reported by a Physician from FRANCE on Oct 03, 2006. Male patient, 73 years of age, weighting 152.1 lb, was diagnosed with chronic myeloid leukaemia and was treated with HYDREA. After drug was administered, patient experienced the following problems/side effects: prostate cancer, prostatic disorder, prostatic specific antigen increased. HYDREA dosage: unknown. During the same period patient was treated with BUSULFAN, MELPHALAN, INTERFERON ALFA, GLEEVEC. Patient recovered.
Health Professional from JAPAN reported HYDREA problem on Dec 01, 2005. Female patient, 68 years of age, was diagnosed with essential thrombocythaemia and was treated with HYDREA. After drug was administered, patient experienced the following problems/side effects: hodgkin's disease, hypoglycaemia, liver disorder, metabolic acidosis, treatment related secondary malignancy. HYDREA dosage: unknown. During the same period patient was treated with ADRIAMYCIN PFS, BLEOMYCIN, VINCREX SULPHATE, DACARBAZINE, ADALAT, GASTER D, GASLON N. Patient was hospitalized. Patient died on 12/09/2005.
HYDREA problem was reported by a Consumer or non-health professional from AUSTRALIA on Oct 23, 2006. Female patient, 88 years of age, was diagnosed with embolism venous and was treated with HYDREA. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia, thrombocytopenia. HYDREA dosage: unknown. During the same period patient was treated with OSTELIN, CALTRATE, GENTAMICIN, TIMENTIN. Patient recovered.
Health Professional from FRANCE reported HYDREA problem on Oct 30, 2006. Male patient, 73 years of age, was diagnosed with chronic myeloid leukaemia and was treated with HYDREA. HYDREA dosage: unknown. Patient died on 10/24/2006.
HYDREA problem was reported by a Health Professional from SWEDEN on Oct 30, 2006. Male patient, 85 years of age, was diagnosed with thrombocytopenia and was treated with HYDREA. After drug was administered, patient experienced the following problems/side effects: cardiac failure, interstitial lung disease, oral candidiasis. HYDREA dosage: unknown. Patient was hospitalized. Patient recovered.
Physician from GERMANY reported HYDREA problem on Oct 27, 2006. Female patient, 57 years of age, was diagnosed with myelofibrosis and was treated with HYDREA. After drug was administered, patient experienced the following problems/side effects: bronchopneumonia. HYDREA dosage: unknown. During the same period patient was treated with CAPTOPRIL, TORSEMIDE, ASPIRIN, AMLODIPINE, METOPROLOL TARTRATE, PANTOPRAZOLE, ISOSORBIDE DINITRATE, LOSARTAN POSTASSIUM. Patient was hospitalized. Patient recovered.
HYDREA problem was reported by a Health Professional from FRANCE on Dec 06, 2006. Female patient, 55 years of age, was diagnosed with myelofibrosis and was treated with HYDREA. After drug was administered, patient experienced the following problems/side effects: cardiac failure. HYDREA dosage: unknown. Patient was hospitalized. Patient recovered.
Health Professional from KOREA, REPUBLIC OF reported HYDREA problem on Nov 30, 2006. Male patient, 83 years of age, was diagnosed with chronic myeloid leukaemia, pancreatic carcinoma and was treated with HYDREA. After drug was administered, patient experienced the following problems/side effects: diarrhoea infectious, neutropenia, pleural effusion, rash, renal failure acute, respiratory failure, thrombocytopenia. HYDREA dosage: unknown. During the same period patient was treated with ALLOPURINOL, GEMCITABINE, AMINOGLYCOSIDES. Patient was hospitalized. Patient died.
HYDREA problem was reported by a Consumer or non-health professional from JAPAN on Dec 06, 2006. Male patient, 77 years of age, was diagnosed with essential thrombocythaemia and was treated with HYDREA. After drug was administered, patient experienced the following problems/side effects: nocardiosis. HYDREA dosage: unknown. Patient died.
Consumer or non-health professional from UNITED KINGDOM reported HYDREA problem on Dec 07, 2006. Male patient, 62 years of age, was diagnosed with essential thrombocythaemia and was treated with HYDREA. After drug was administered, patient experienced the following problems/side effects: malignant melanoma. HYDREA dosage: unknown. Patient recovered.
HYDREA problem was reported by a Health Professional from FRANCE on Dec 19, 2006. Male patient, 72 years of age, weighting 160.9 lb, was diagnosed with chronic myeloid leukaemia, atrial fibrillation and was treated with HYDREA. After drug was administered, patient experienced the following problems/side effects: lymphoma. HYDREA dosage: unknown. During the same period patient was treated with ARACYTINE, INTERFERON ALFACON, GLEEVEC, FLECAINIDE ACETATE. Patient recovered.
Health Professional from FRANCE reported HYDREA problem on July 16, 2007. Male patient, 17 years of age, was diagnosed with acute myeloid leukaemia, bronchopulmonary aspergillosis and was treated with HYDREA. After drug was administered, patient experienced the following problems/side effects: arrhythmia, bronchopulmonary aspergillosis, cardio-respiratory arrest, cerebellar syndrome, coma, convulsion, eye movement disorder, hepatic function abnormal, hyperthermia. HYDREA dosage: unknown. During the same period patient was treated with AMIKLIN, CERUBIDINE, ARACYTINE, NOVANTRONE, METHOTREXATE, AMSACRINE, TAZOCILLINE. Patient was hospitalized. Patient died on 06/10/2007.
HYDREA problem was reported by a Health Professional from FRANCE on Aug 29, 2007. Male patient, 61 years of age, was diagnosed with leukocytosis, chronic myeloid leukaemia and was treated with HYDREA. After drug was administered, patient experienced the following problems/side effects: adenocarcinoma. HYDREA dosage: unknown. During the same period patient was treated with GLEEVEC, CYTARABINE. Patient recovered.
Consumer or non-health professional from FRANCE reported HYDREA problem on Aug 31, 2007. Male patient, 63 years of age, was diagnosed with chronic myeloid leukaemia, atrial fibrillation and was treated with HYDREA. After drug was administered, patient experienced the following problems/side effects: adenocarcinoma, free prostate-specific antigen decreased, prostate cancer, prostatic specific antigen increased. HYDREA dosage: unknown. During the same period patient was treated with CORDARONE, GLEEVEC. Patient was hospitalized. Patient recovered.
HYDREA problem was reported by a Health Professional from UNITED KINGDOM on Sept 13, 2007. Female patient, weighting 141.1 lb, was treated with HYDREA. After drug was administered, patient experienced the following problems/side effects: accidental exposure, atrioventricular block, dizziness, headache, painful respiration, syncope. HYDREA dosage: unknown. Patient was hospitalized. Patient recovered.
Physician from FRANCE reported HYDREA problem on Sept 14, 2007. Male patient, 61 years of age, was diagnosed with chronic myeloid leukaemia and was treated with HYDREA. After drug was administered, patient experienced the following problems/side effects: adenocarcinoma, bone pain, metastases to bone, metastasis. HYDREA dosage: unknown. During the same period patient was treated with CYTARABINE, GLEEVEC, IMODIUM, ALLOPURINOL, TAHOR. Patient recovered.
HYDREA problem was reported by a Physician from JAPAN on Sept 18, 2007. Male patient, 50 years of age, was diagnosed with chronic myeloid leukaemia and was treated with HYDREA. After drug was administered, patient experienced the following problems/side effects: ventricular tachycardia. HYDREA dosage: unknown. Patient recovered.